|Project manager:||Dr Louise Maple-Brown|
|Project start/finish dates:||2007-2011|
|For more information about this project please contact:|
There is an overwhelming burden of type 2 diabetes, chronic kidney disease and end-stage renal failure in Indigenous Australians. In this high risk population, it is vital that we are able to accurately measure kidney function. Glomerular filtration rate (GFR) is the best overall marker of kidney function. However, differences in body build and body composition between Indigenous and non-Indigenous Australians suggest that estimates of GFR derived for European populations may not be appropriate for Indigenous Australians. The burden of kidney disease is borne disproportionately by Indigenous Australians in central and northern Australia, with significant heterogeneity amongst these groups, thus differences in body build and body composition likely also affect the accuracy of GFR between different Indigenous groups. By assessing kidney function in these high risk Indigenous Australian populations from Northern Queensland, Northern Territory and Western Australia, we aim to determine a validated and practical measure of GFR suitable for use in all Indigenous Australians. The eGFR Study is a multi-centre study recruiting adult Indigenous Australian participants across 5 strata of health, diabetes status and kidney function.
More information about the study can be found below.